{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5d6ceede192044a676279435/688331873781311f911e2916?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Joacim Holter om biotech og nanotech","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5d6ceede192044a676279435/1753427844291-73aac39f-bcb7-4120-8a53-7ed2c5c135fd.jpeg?height=200","description":"<p>Joacim Holter er&nbsp;administrerende&nbsp;direktør&nbsp;i&nbsp;Lifecare ASA, et&nbsp;norsk&nbsp;medisinteknologiselskap&nbsp;som&nbsp;utvikler&nbsp;banebrytende&nbsp;sensorteknologi&nbsp;for&nbsp;blant&nbsp;annet&nbsp;diabetesbehandling. Med&nbsp;bakgrunn&nbsp;som&nbsp;jurist&nbsp;og&nbsp;over 20&nbsp;års&nbsp;erfaring&nbsp;fra&nbsp;næringslivet,&nbsp;har&nbsp;han&nbsp;hatt&nbsp;en&nbsp;sentral&nbsp;rolle&nbsp;i&nbsp;både&nbsp;nasjonale&nbsp;og&nbsp;internasjonale&nbsp;teknologiselskaper. Holter&nbsp;har&nbsp;tidligere vert styreleder for&nbsp;sveitsiske&nbsp;Osmotex&nbsp;AG&nbsp;og&nbsp;har&nbsp;vært&nbsp;en&nbsp;viktig&nbsp;drivkraft&nbsp;i&nbsp;Lifecare&nbsp;siden&nbsp;2011 –&nbsp;først&nbsp;som&nbsp;styreleder,&nbsp;og&nbsp;nå&nbsp;som&nbsp;CEO. I&nbsp;denne&nbsp;episoden&nbsp;deler&nbsp;han&nbsp;innsikt&nbsp;i&nbsp;hvordan&nbsp;teknologi&nbsp;og&nbsp;helse&nbsp;smelter&nbsp;sammen,&nbsp;og&nbsp;hva&nbsp;som&nbsp;kreves&nbsp;for å&nbsp;lykkes&nbsp;i&nbsp;det&nbsp;globale&nbsp;medtech-markedet.&nbsp;</p><p><br></p><p>NB! På grunn av strømbrudd stopper episoden litt brått.</p><p>&nbsp;</p><p>Denne&nbsp;episoden&nbsp;ble&nbsp;spilt inn I&nbsp;forbindelse&nbsp;med&nbsp;<a href=\"https://www.bi.no/studier-og-kurs/videreutdanning/kompetanseheving-bransjeprogram/digital-transformasjon-i-finansnaringen/\" rel=\"noopener noreferrer\" target=\"_blank\">BI-kurset Digital transformasjon I finansnæringen</a>. Jeg&nbsp;har&nbsp;vurdert&nbsp;denne&nbsp;samtalen&nbsp;til&nbsp;å ha interesse&nbsp;utenfor&nbsp;finansnæringen,&nbsp;og&nbsp;den er&nbsp;derfor&nbsp;åpent&nbsp;publisert&nbsp;etter&nbsp;avtale&nbsp;med&nbsp;både&nbsp;samtalepartner,&nbsp;<a href=\"http://www.bi.no/\" rel=\"noopener noreferrer\" target=\"_blank\">Handelshøyskolen BI</a>,&nbsp;og&nbsp;samarbeidspartnerne&nbsp;i&nbsp;kurset:&nbsp;<a href=\"http://www.finansforbundet.no/\" rel=\"noopener noreferrer\" target=\"_blank\">Finansforbundet</a>,&nbsp;<a href=\"http://www.sparebank1.no/\" rel=\"noopener noreferrer\" target=\"_blank\">Sparebanken1</a>&nbsp;og&nbsp;<a href=\"http://www.finansnorge.no/\" rel=\"noopener noreferrer\" target=\"_blank\">Finans Norge</a>.&nbsp;</p>","author_name":"Tarjei Heggernes"}